Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 04. 25.
 Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2013.11.14. 11:32:57   Á¶È¸: 4224
2013³â 11¿ù 10ÀÏ~13ÀϱîÁö ÀϺ» ¿À»çÄ«, ¿À»çÄ«±¹Á¦È¸ÀÇÀå¿¡¼­ Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ Çмú´ëȸ°¡ ¼ºÈ²¸® °³ÃֵǾú´Ù.
Âü°¡ÀÚµéÀº Àü¼¼°è¸¦ Æ÷ÇÔÇÏ¿© ¹Ì±¹, À¯·´, È£ÁÖ, ´ºÁú¶õµå, Áß±¹, ÀϺ», Çѱ¹µî¿¡¼­ ¾à 400 ¿©¸íÀÇ ÀÌÁ¾À̽Ŀ¬±¸ °ü·ÃÇÐÀÚµéÀÌ 4ÀÏ°£ 400 ¿©ÆíÀÇ ÀÌÁ¾À̽İü·Ã ¿¬±¸¹ßÇ¥¿Í Ư°­, ½ÉÆ÷Áö¿òµîÀ¸·Î ¿­¶í Çмú´ëȸ°¡ ÁøÇàµÇ¾ú´Ù.
Çѱ¹¿¡¼­µµ ¿©·¯´ëÇп¡¼­ ¸¹Àº ¿¬±¸ÁøÀÌ Âü¼®ÇÏ¿´À¸¸ç ÃÊû°­¿¬, ¿¬±¸¹ßÇ¥¸¦ ½ÃÇàÇÏ¿´´Ù. ƯÈ÷ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿¬±¸ÁøÀÌ Çѱ¹ ´ëÇ¥µéÀÇ ÁÖ·ù¸¦ ÀÌ·ç°í ÃÊû°­ÀÇ, ÁÂÀå, ½Ê¿©ÆíÀÇ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ¼­¿ï´ëÇб³º´¿ø ÈäºÎ¿Ü°ú¿¡¼­µµ  Development of novel combined anticalcification protocol including immunologic modification for prolonged durability of cardiac xenograft in animal study¿Í In-vivo efficacy for treatment with decellularization, alpha-galactosidase, spacefiller, organic solvent and detoxifixation of GA-fixed cardiac xenograft using alpha-gal mouse implantation model À̶õ ¿¬Á¦¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ±Ý³â¿¡´Â alpha-gal KO pig¿¡ genetic modification ÁøÇàÀÌ ´õ¿í ÇöÀúÇÏ°í, genetically induced disease(agenesis) model°³¹ß, chimerism ¹æ¹ýµµ ´«ºÎ½Ã°Ô ¹ßÀüµÇ¾ú´Ù. Çѱ¹µµ ÀÌ·¯ÇÑ ÀÌÁ¾À̽Ŀ¡¼­ À¯ÀüÀÚ Ã³¸® ±â¼úµéÀÌ »¡¸® Çâ»óµÇ±æ ±â¿øÇÑ´Ù.
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 04. 25.  Àüü±Û: 211  ¹æ¹®¼ö: 1023760
127 Á¦55Â÷ ´ëÇѽÉÀåÇÐȸ Ãß°èÇмú´ëȸ °ü¸®ÀÚ2011.12.05.4101
126 Á¦ 43Â÷ ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ °ü¸®ÀÚ2011.11.10.4248
125 Á¦ 14Â÷ ¼Ò¾Æ½ÉÀå¿Ü°ú ½ÉÆ÷Áö¿ò °ü¸®ÀÚ2011.11.10.4616
124 Á¦25Â÷ À¯·´ÈäºÎ¿Ü°úÇÐȸ °ü¸®ÀÚ2011.10.11.4185
123 ÀÌÁ¾Àå±â °¡À» workshop °ü¸®ÀÚ2011.09.29.4105
122 Á¦ 47Â÷ ÀϺ»¼Ò¾Æ¼øȯ±âÇÐȸ ¹× Á¦ 7Â÷ ÇÑÁßÀÏ ¼Ò¾Æ½ÉÀåÇÐȸ °ü¸®ÀÚ2011.07.11.4164
121 Áß±¹ ¿¬º¯´ëÇÐ º¹Áöº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2011.06.20.4145
120 2011 ASCVTS-ATCSA Joint Meeting °ü¸®ÀÚ2011.05.27.4193
119 ÇϾóºóÀÇ´ë, ´ëÇк´¿ø°£ Çй®±³·ùÇù¾à °ü¸®ÀÚ2011.05.23.4707
118 Áß±¹ Èæ·æ°­¼º ½ÉÀå¼ö¼ú °ü¸®ÀÚ2011.04.30.3959
RELOAD WRITE
[1] [2] [3] [4] [5] [6] [7] [8] 9 [10]  ¢º 22